splitting doses of tirzepatide Microdosing (Mounjaro/Zepbound): Evidence-Based Split Dosing Strategies Split Tirzepatide Doses Safely |
Description
The prescribing information does list dyspepsia (indigestion) as a common adverse reaction, which is characterized by epigastric discomfort or pain

CagriSema: Two Molecules, Complementary Mechanisms CagriSema combines two existing molecules in a fixed-dose injection
Understanding this pharmacological basis helps patients and clinicians anticipate and proactively manage this adverse effect

[5] Modern Peptide Therapies for Metabolic Conditions Advances in peptide therapies have expanded options for addressing metabolic dysfunction

Because tirzepatide reduces appetite significantly, meeting these targets requires intentional food selection and tracking, especially in the first 48 weeks of treatment
This is why the 4-week minimum at each dose level exists
